Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Swine Genetics International (SGI) is a premier biotechnology company specializing in porcine genetics and reproductive technologies, based in Cambridge, Iowa. Founded in 1981, the company is a global leader in the production and distribution of high-quality swine semen, offering genetics from elite breeds including Duroc, Hampshire, Landrace, and Yorkshire. SGI utilizes advanced genomic selection and cryopreservation techniques to enhance traits such as growth efficiency, meat quality, and disease resistance in commercial swine herds. The company provides a comprehensive range of services, including genetic consulting, artificial insemination equipment, and technical training for producers worldwide. As a subsidiary of The Maschhoffs, SGI leverages extensive industry expertise to drive genetic progress and improve the sustainability of the global pork supply chain. With exports to over 35 countries, SGI remains a critical partner for international swine producers seeking superior genetic performance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Swine Genetics.